Latest filings (excl ownership)
6-K
Current report (foreign)
21 May 24
6-K
Current report (foreign)
1 May 24
20-F
2023 FY
Annual report (foreign)
1 May 24
NT 20-F
Notice of late annual filing (foreign)
1 May 24
6-K
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBIDTA of over NIS 50 million
1 Apr 24
6-K
InterCure Provides an Update Regarding Nir Oz Facility
13 Feb 24
6-K
Current report (foreign)
13 Feb 24
6-K
InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain
31 Jan 24
6-K
Current report (foreign)
14 Dec 23
6-K
Annual General Meeting of Shareholders to Be
8 Nov 23
6-K
Current report (foreign)
31 Oct 23
6-K
InterCure Provides an Update Regarding the Security Situation in Israel
17 Oct 23
6-K
InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY
31 Aug 23
6-K
Current report (foreign)
14 Aug 23
6-K
Notice of Special Meeting of Shareholders
24 Jul 23
6-K
InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE
11 Jul 23
6-K
InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger
12 Jun 23
6-K
InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY
16 May 23
20-F
2022 FY
Annual report (foreign)
1 May 23
6-K
InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary
26 Apr 23
6-K
Current report (foreign)
25 Apr 23
6-K
InterCure Ltd. Partners with TYSON 2.0 in Israel, Australia, United Kingdom, Germany and Other EU Countries
20 Apr 23
6-K
InterCure Announces Reschedules 2022 Full Year Results Conference Call
3 Apr 23
6-K
InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results
3 Apr 23
6-K
Intercure Files Lawsuit Against Cann Pharmacuticals to Recover Funds Following Failed Merger
14 Feb 23
6-K
Current report (foreign)
1 Feb 23
6-K
InterCure Announces Exclusive
19 Dec 22
6-K
InterCure Announces the Withdrawal of a Class Action Lawsuit against it
5 Dec 22
6-K
Update regarding Better Transaction
23 Nov 22
6-K
Current report (foreign)
17 Nov 22
6-K
Condensed Consolidated Interim Financial Statements
16 Nov 22
6-K
Current report (foreign)
18 Aug 22
6-K
Current report (foreign)
15 Jul 22
EFFECT
Notice of effectiveness
27 Jun 22
POS AM
Prospectus update (post-effective amendment)
23 Jun 22
6-K
InterCure Begins 2022 with Record Breaking First Quarter Financial Results
24 May 22
20-F
2021 FY
Annual report (foreign)
28 Apr 22
6-K
Current report (foreign)
7 Apr 22
6-K
InterCure Reports Record Preliminary 2021 Fourth Quarter Revenue - 3 Times YoY and 24% QoQ Growth
9 Feb 22
6-K
Extraordinary General Meeting of Shareholders
4 Jan 22
Latest ownership filings